| Primary information |
|---|
| ID | 13557 |
| Uniprot ID | Q2PE51 |
| Description | Bradykinin-potentiating and C-type natriuretic peptides (Angiotensin converting enzyme inhibitor-CNP) (ACEI-CNP) (BPP-CNP) [Cleaved into- Bradykinin-potentiating peptide-1 (BPP-1); Bradykinin-potentiating peptide-2 (BPP-2); Bradykinin inhibitor peptide homolog (Cdc peptide) (Novel peptide); C-type n |
| Organism | Crotalus durissus collilineatus |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria (diapsids); Lepidosauria (lepidosaurs); Squamata (squamates); Bifurcata (split-tongued squamates); Unidentata; Episquamata; Toxicofera; Serpentes (snakes); Colubroidea; Viperidae; Crotalinae (pit vipers); Crotalus; Crotalus durissus (tropical rattlesnake); Cro |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | In the N-terminal section; belongs to the bradykinin-potentiating peptide family. |
| Tissue Specificity | Venom gland. |
| Post Translational Modification | NA |
| Function | Bradykinin-potentiating peptide both inhibits the activity of the angiotensin-converting enzyme (ACE) and enhances the action of bradykinin by inhibiting the peptidases that inactivate it. It acts as an indirect hypotensive agent. |
| Length | 181 |
| Molecular Weight | 18 |
| Name | NA |
| Sequence | NA |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|